Portolan Capital Management’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-129,144
| Closed | -$3M | – | 135 |
|
|
2024
Q3 | $3M | Sell |
129,144
-355,763
| -73% | -$8.26M | 0.22% | 110 |
|
|
2024
Q2 | $11.8M | Buy |
484,907
+240,248
| +98% | +$5.85M | 0.97% | 38 |
|
|
2024
Q1 | $8.26M | Buy |
244,659
+98,805
| +68% | +$3.34M | 0.63% | 59 |
|
|
2023
Q4 | $4.6M | Sell |
145,854
-130,651
| -47% | -$4.12M | 0.4% | 81 |
|
|
2023
Q3 | $7.06M | Buy |
+276,505
| New | +$7.06M | 0.66% | 48 |
|